자기공명영상(MRI) 시스템 시장 - 세계 및 지역별 분석 : 자장 강도, 아키텍처, 설계, 용도, 최종사용자, 지역별 - 분석과 예측(2026-2036년)

This report can be delivered within 1 working day.

Global Magnetic Resonance Imaging (MRI) Systems Market Industry Overview

MRI systems are advanced diagnostic imaging modalities used to generate detailed images of internal organs, soft tissues, bones, vascular structures, and functional abnormalities without ionizing radiation. MRI systems have applications across neurology, oncology, musculoskeletal imaging, cardiology, and other complex diagnostic workflows. Demand is supported by the need for high-resolution soft-tissue visualization, early disease detection, disease staging, treatment planning, and longitudinal monitoring.

Technology development is focused on faster acquisition, AI-assisted reconstruction, automated scan planning, patient-centric bore design, helium-efficient or helium-independent magnet systems, and portable or low-field platforms. These advances address long scan times, high operating costs, site planning constraints, patient comfort limitations, and access barriers in underserved or decentralized care settings. The growing adoption of digitally connected MRI platforms includes workflow automation, remote monitoring, and compatibility with existing imaging infrastructure.

Market Introduction

Market transformation is being shaped by both clinical demand and operational pressure. On the demand side, MRI's diagnostic value is expanding as healthcare systems emphasize early detection, precision diagnosis, and chronic disease management. On the operational side, radiology departments must manage higher imaging volumes, limited staff availability, and pressure to improve throughput. These conditions support adoption of high-performance scanners, AI reconstruction, automated workflow tools, wider bores, and improved magnet designs that can increase capacity without proportionally increasing installed base.

Industrial Impact

Industrial impact is visible in the shift from scanner procurement toward lifecycle imaging ecosystems. Hospitals and diagnostic imaging centers increasingly evaluate MRI systems not only by magnet strength and image quality, but also by throughput, serviceability, AI-enabled reconstruction, remote support, helium sustainability, patient comfort, interoperability, and integration with PACS, RIS, and broader enterprise imaging environments. Vendors that combine hardware, software, workflow automation, and service support are better positioned to address the operational burden facing imaging providers.

MRI accessibility is being reshaped by low-field, portable, and helium-light designs. These platforms can reduce infrastructure requirements and support bedside, emergency, rural, or underserved settings. However, advanced high-field platforms remain central to complex diagnostic workflows in mature health systems because of their superior image resolution, signal-to-noise ratio, and protocol flexibility. The industrial opportunity therefore spans both high-end replacement cycles and access-oriented expansion.

Regulatory and compliance expectations also shape the industrial impact of the market. North America acts as a mature, risk-based environment in which MRI manufacturers must address electrical safety, electromagnetic compatibility, magnetic-field exposure, radiofrequency energy deposition, gradient-induced stimulation, acoustic noise, patient heating, implant interactions, software documentation, cybersecurity, labeling, and lifecycle monitoring.

Commercially, the procurement decisions are shaped by capital cost, facility requirements, service reliability, staffing availability, reimbursement environments, and integration with hospital information systems. Hospitals with high patient volumes prioritize scanner utilization, protocol flexibility, emergency and inpatient imaging support, and the ability to handle advanced neurological, oncological, cardiovascular, and musculoskeletal workflows. Diagnostic imaging centers often emphasize throughput, scheduling efficiency, patient comfort, and cost-effective outpatient operations. Emerging markets and rural settings may prioritize lower infrastructure complexity, portable access, and support models that reduce dependence on highly specialized facilities. These different buyer requirements create multiple pathways for growth, ranging from premium high-field upgrades to access-oriented low-field and portable deployments.

Market Segmentation:

Segmentation 1: By Field Strength

• High and Very High Field MRI Systems
• Low and Mid-Field MRI Systems

High and Very High Field MRI Systems Segment to Dominate the Global Magnetic Resonance Imaging (MRI) Systems Market (by Field Strength)

High and very high field MRI systems include 1.5T and 3T platforms, along with emerging ultra-high-field systems used in advanced research and specialized clinical settings. These systems offer superior image resolution, signal-to-noise ratio, and soft-tissue contrast, making them important for neurology, oncology, musculoskeletal imaging, functional MRI, cardiac imaging, and advanced neuroimaging. Their dominance is supported by strong clinical relevance, use in high-volume hospitals and specialty imaging settings, and continued innovation in gradient performance, coil technology, AI-assisted reconstruction, faster acquisition sequences, and wide-bore patient-centric designs.

Segmentation 2: By Architecture

• Closed MRI Systems
• Open MRI Systems

Closed MRI Systems Segment to Dominate the Global Magnetic Resonance Imaging (MRI) Systems Market (by Architecture)

Closed MRI systems are expected to lead by architecture because they represent the conventional scanner configuration across hospitals, diagnostic imaging centers, and specialty care settings. These systems have a broad installed base, procurement familiarity, consistent image quality, protocol flexibility, dependable performance, high-field magnet compatibility, and suitability for high-throughput workflows. Open systems are important for claustrophobic, obese, pediatric, and physically challenged patients and are benefiting from coil and AI-based enhancement, but they generally start from a smaller adoption base and may face resolution or throughput trade-offs.

Segmentation 3: By Design

• Portable
• Fixed/Stationary

Fixed/Stationary Segment to Dominate the Global Magnetic Resonance Imaging (MRI) Systems Market (by Design)

Fixed or stationary MRI systems lead by design because they form the backbone of diagnostic imaging infrastructure in hospitals and imaging centers. These systems are installed in dedicated MRI suites and can support high-throughput routine and complex diagnostic procedures across multiple clinical specialties. Their dominance is supported by compatibility with high-field and very high-field configurations, advanced gradients, specialized coils, controlled environments, stable performance, and continuous utilization.

Segmentation 4: By Application

• Neurology
• Musculoskeletal
• Oncology
• Cardiology
• Others

Neurology Segment to Dominate the Global Magnetic Resonance Imaging (MRI) Systems Market (by Application)

Neurology leads by application because MRI provides high-resolution, non-invasive visualization of the brain, spine, central nervous system, and related soft-tissue structures. MRI is central to conditions such as stroke, brain tumors, epilepsy, multiple sclerosis, neurodegenerative disorders, spinal cord abnormalities, and traumatic brain injuries. Neurological imaging often requires advanced sequences, diffusion imaging, functional imaging, contrast techniques, and repeat examinations for diagnosis and follow-up. This supports sustained scanner utilization across acute and chronic neurological care pathways.

Segmentation 5: By End User

• Hospitals
• Diagnostic Imaging Centers
• Others

Hospitals Segment to Dominate the Global Magnetic Resonance Imaging (MRI) Systems Market (by End User)

Hospitals lead by end user because they are primary centers for advanced diagnosis, emergency care, inpatient management, and multidisciplinary treatment planning. MRI systems in hospitals support surgery, oncology, neurology, orthopedics, cardiology, and critical care workflows. Hospitals are also better positioned to support infrastructure requirements such as dedicated scanner rooms, shielding, patient monitoring, anesthesia support, trained radiology teams, and service maintenance.

Segmentation 6: By Region

• North America
• Europe
• Asia-Pacific
• Rest-of-the-World

North America to Dominate the Global Magnetic Resonance Imaging (MRI) Systems Market (by Region)

North America leads the regional market because the region has established diagnostic imaging infrastructure, strong adoption of advanced medical technologies, mature healthcare delivery networks, and broad access to hospitals, diagnostic imaging centers, specialty clinics, and academic medical institutions that routinely use MRI for complex clinical applications. The region emphasizes early disease detection, precision diagnosis, and high-quality imaging outcomes, which supports demand for advanced platforms with improved resolution, faster scan times, and workflow efficiency.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

A major driver is the rising burden of neurological and oncological diseases. MRI plays a central role in diagnosing and monitoring conditions such as stroke, Alzheimer's disease, epilepsy, multiple sclerosis, brain tumors, spinal disorders, cancer, and orthopedic injuries. According to the World Health Organization, more than 3 billion people globally were living with a neurological condition in 2021, making neurological disorders the leading cause of illness and disability worldwide, with disability-adjusted life years (DALYs) increasing by 18% since 1990. Further, global cancer cases are also projected to increase severalfold by 2050. These disease trends create recurring demand for soft-tissue imaging, staging, treatment planning, and treatment response evaluation, reinforcing MRI utilization across both mature and emerging health systems.

Market Challenges

The primary challenge is the shortage of skilled radiologists and MRI technologists. MRI is a technically complex modality that requires specialized expertise for protocol selection, image acquisition, patient safety, and diagnostic interpretation. The rising imaging volumes are outpacing workforce growth, creating reporting backlogs and operational strain. It also highlights major disparities in radiologist availability, with many low-income countries compared with the radiologists available in developed markets. These gaps limit the ability of health systems to scale MRI services even when systems are installed. Workforce pressure reduces effective scanner utilization and weakens the return on imaging infrastructure. Shortages can lead to longer turnaround times, repeat imaging, suboptimal protocol execution, and limited access outside major urban centers.

Market Opportunities

The main opportunity is the emergence of vendor-neutral and interoperable MRI ecosystems. Today, pulse sequences, reconstruction methods, workflow software, and quantitative imaging outputs remain largely proprietary to individual manufacturers. This creates variability across scanners and limits reproducibility in multi-site studies, longitudinal imaging, and AI validation. Vendor-neutral acquisition and workflow approaches can help standardize imaging protocols across mixed fleets, reduce workflow fragmentation, simplify radiologist interpretation, and support more consistent imaging biomarkers in neurology, oncology, and cardiac imaging.

Vendor-neutral MRI ecosystems could support enterprise imaging networks, federated AI training, standardized clinical pathways, and scalable precision imaging strategies. Commercial implementation is still limited, but the opportunity is strategically important because future differentiation may shift from scanner hardware alone toward interoperable imaging environments, cloud-connected reconstruction, cross-platform AI deployment, and harmonized quantitative imaging outputs. Vendors that move toward open, reproducible, and enterprise-ready imaging ecosystems could strengthen their relevance to large hospital networks, academic centers, and multi-site clinical research groups.

How can this report add value to an organization?

Product/Innovation Strategy: The report can support product strategy by identifying where innovation priorities are concentrated: high-field and very high-field systems, helium-efficient magnets, AI-assisted reconstruction, automated scan planning, patient-centric bore design, portable or low-field systems, and interoperable imaging platforms. Vendors can use this insight to prioritize features that address image quality, throughput, cost of ownership, access, and workflow automation.

Growth/Marketing Strategy: Growth strategy can be informed by the regional and segment data. North America remains the largest regional market, while Asia-Pacific shows strong growth potential. High and very high field systems dominate value, fixed systems remain central to hospital imaging infrastructure, and neurology is the leading application. These findings help suppliers target sales messaging by region, care setting, clinical use case, and infrastructure readiness.

Competitive Strategy: Competitive strategy can be strengthened by mapping key OEM positioning, recent product launches, regulatory clearances, partnerships, and innovation themes. The developments table shows activity around portable MRI approvals, helium-light MRI, AI workflow ecosystems, AI-powered installations, neuroimaging analytics, and next-generation 3T systems. These developments indicate that differentiation is increasingly tied to workflow intelligence, regulatory execution, access expansion, and magnet sustainability.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• Years from 2024 to 2036 have been considered for the global market size estimation; 2025 has been considered as the base year, and 2026 to 2036 as the forecast period.
• The scope of the report is based on comprehensive inputs from industry experts and key stakeholders across the healthcare and MRI ecosystem, including MRI system manufacturers, diagnostic imaging equipment providers, radiology service providers, and healthcare institutions.
• The market contribution of MRI systems is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
• Revenues from companies have been sourced from their annual reports for FY2024 and FY2025. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
• The market has been mapped based on the existing MRI systems. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts and key stakeholders across the healthcare and MRI ecosystem, including MRI system manufacturers, diagnostic imaging equipment providers, radiology service providers, and healthcare institutions. Stakeholders such as hospitals, diagnostic imaging centers, specialty clinics, and radiology departments have been consulted to validate adoption trends, procurement preferences, technology upgrades, workflow requirements, and clinical utility specific to MRI systems. Respondents, including CEOs, vice presidents, product and marketing directors, radiology administrators, imaging department heads, and technology and innovation leaders, have been interviewed to obtain and verify both qualitative and quantitative insights for this research study.

The key data points taken from the primary sources include:

• validation and triangulation of all the numbers and graphs
• validation of report segmentations and key qualitative findings
• understanding the competitive landscape and business model
• current and proposed production values of a product by market players
• validation of the numbers of different segments of the market in focus
• percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
• Annual reports, SEC filings, and investors' presentations of the leading market players
• Company websites and a detailed study of their product portfolio
• Gold standard magazines, journals, white papers, press releases, and news articles
• Paid databases

The key data points taken from the secondary sources include:

• segmentations and percentage shares
• data for market value
• key industry trends of the top players in the market
• qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The MRI systems market is a consolidated, technology-intensive diagnostic imaging industry in which established OEMs compete on scanner performance, workflow efficiency, patient comfort, magnet sustainability, software integration, and service support. Established manufacturers such as Siemens Healthineers, GE HealthCare, Koninklijke Philips N.V., Canon Inc., and FUJIFILM Holdings Corporation maintain strong positions through broad portfolios, service networks, and hospital relationships. Specialist and emerging companies, including Hyperfine, Esaote, FONAR, ASG Superconductors, Aurora Healthcare, Shanghai United Imaging, and Synaptive Medical, add competition through dedicated imaging solutions, portable systems, open or upright configurations, superconducting magnets, neurosurgical applications, and point-of-care imaging devices.

Competition is increasingly shifting from a hardware-centric model toward a solution-oriented ecosystem. The source report highlights differentiation around high-field and very high-field platforms, wide-bore designs, helium-efficient or helium-independent magnets, AI-assisted reconstruction, automated scan planning, quieter scanning, advanced coils, remote monitoring, and digitally connected imaging environments. These capabilities influence procurement decisions because hospitals and imaging centers require systems that can raise throughput, improve image quality, reduce operational complexity, and integrate with existing diagnostic infrastructure.

Some prominent names established in this market are:

• ASG Superconductors spa
• AURORA HEALTHCARE US CORP
• Canon Inc.
• Esaote SPA
• FONAR Corporation
• FUJIFILM Holdings Corporation
• GE Healthcare
• Hyperfine, Inc.
• Koninklijke Philips N.V.
• Neusoft Medical Systems Co., Ltd.
• Shanghai United Imaging Healthcare Co., Ltd.
• Siemens Healthineers AG
• SternMed GmbH
• Synaptive Medical
• Time Medical Holding

Table of Contents

Executive Summary

Scope and Definition

1 Global Magnetic Resonance Imaging (MRI) Systems Market: Industry Outlook

• 1.1 Market Overview
• 1.2 Market Trends
  • 1.2.1 Impact Analysis
    • 1.2.1.1 Helium-Independent MRI Systems Supporting Cost Efficiency and Sustainability Goals
    • 1.2.1.2 Increasing Use of MRI in Preventive and Screening Applications
• 1.3 Regulatory Landscape
  • 1.3.1 Regulatory Landscape in North America
    • 1.3.1.1 Regulatory Landscape in the U.S.
  • 1.3.2 Regulatory Landscape in Europe
    • 1.3.2.1 Regulatory Landscape in the EU Countries
    • 1.3.2.2 Regulatory Landscape in the U.K.
  • 1.3.3 Regulatory Landscape in Asia-Pacific
    • 1.3.3.1 Regulatory Landscape in Japan
    • 1.3.3.2 Regulatory Landscape in China
    • 1.3.3.3 Regulatory Landscape in India
    • 1.3.3.4 Regulatory Landscape in Australia
  • 1.3.4 Regulatory Landscape in the Other Countries
• 1.4 Market Dynamics
  • 1.4.1 Market Drivers
    • 1.4.1.1 Rising Burden of Neurological and Oncological Diseases Driving MRI Utilization
    • 1.4.1.2 Integration of Artificial Intelligence (AI) Enhancing Workflow Efficiency and Throughput
  • 1.4.2 Market Challenges
    • 1.4.2.1 Shortage of Skilled Radiologists and MRI Technologists
  • 1.4.3 Market Opportunities
    • 1.4.3.1 Emergence of Vendor-Neutral and Interoperable MRI Ecosystems

2 Global Magnetic Resonance Imaging (MRI) Systems Market (by Field Strength), $Million, 2024-2036

• 2.1 High and Very High Field MRI Systems
  • 2.1.1 Overview
  • 2.1.2 Market Sizing and Forecast
• 2.2 Low and Mid-Field MRI Systems
  • 2.2.1 Overview
  • 2.2.2 Market Sizing and Forecast

3 Global Magnetic Resonance Imaging (MRI) Systems Market (by Architecture), $Million, 2024-2036

• 3.1 Closed MRI Systems
  • 3.1.1 Overview
  • 3.1.2 Market Sizing and Forecast
• 3.2 Open MRI Systems
  • 3.2.1 Overview
  • 3.2.2 Market Sizing and Forecast

4 Global Magnetic Resonance Imaging (MRI) Systems Market (by Design), $Million, 2024-2036

• 4.1 Portable
  • 4.1.1 Overview
  • 4.1.2 Market Sizing and Forecast
• 4.2 Fixed/Stationary
  • 4.2.1 Overview
  • 4.2.2 Market Sizing and Forecast

5 Global Magnetic Resonance Imaging (MRI) Systems Market (by Application), $Million, 2024-2036

• 5.1 Neurology
  • 5.1.1 Overview
  • 5.1.2 Market Sizing and Forecast
• 5.2 Musculoskeletal
  • 5.2.1 Overview
  • 5.2.2 Market Sizing and Forecast
• 5.3 Oncology
  • 5.3.1 Overview
  • 5.3.2 Market Sizing and Forecast
• 5.4 Cardiology
  • 5.4.1 Overview
  • 5.4.2 Market Sizing and Forecast
• 5.5 Others
  • 5.5.1 Overview
  • 5.5.2 Market Sizing and Forecast

6 Global Magnetic Resonance Imaging (MRI) Systems Market (by End User), $Million, 2024-2036

• 6.1 Hospitals
  • 6.1.1 Overview
  • 6.1.2 Market Sizing and Forecast
• 6.2 Diagnostic Imaging Centers
  • 6.2.1 Overview
  • 6.2.2 Market Sizing and Forecast
• 6.3 Others
  • 6.3.1 Overview
  • 6.3.2 Market Sizing and Forecast

7 Global Magnetic Resonance Imaging (MRI) Systems Market (by Region), $Million, 2024-2036

• 7.1 Regional Summary
• 7.2 North America
  • 7.2.1 Regional Overview
  • 7.2.2 Driving Factors for Market Growth
  • 7.2.3 Factors Challenging the Market
  • 7.2.4 Analyst View
  • 7.2.5 Market Sizing and Forecast
    • 7.2.5.1 North America Magnetic Resonance Imaging (MRI) Systems Market, by Country
      • 7.2.5.1.1 U.S.
        • 7.2.5.1.1.1 Country Overview
        • 7.2.5.1.1.2 Driving Factors for Market Growth
        • 7.2.5.1.1.3 Factors Challenging the Market
        • 7.2.5.1.1.4 Analyst View
        • 7.2.5.1.1.5 Market Sizing and Forecast
      • 7.2.5.1.2 Canada
        • 7.2.5.1.2.1 Country Overview
        • 7.2.5.1.2.2 Driving Factors for Market Growth
        • 7.2.5.1.2.3 Factors Challenging the Market
        • 7.2.5.1.2.4 Analyst View
        • 7.2.5.1.2.5 Market Sizing and Forecast
• 7.3 Europe
  • 7.3.1 Regional Overview
  • 7.3.2 Driving Factors for Market Growth
  • 7.3.3 Factors Challenging the Market
  • 7.3.4 Analyst View
  • 7.3.5 Market Sizing and Forecast
    • 7.3.5.1 Europe Magnetic Resonance Imaging (MRI) Systems Market, by Country
      • 7.3.5.1.1 U.K.
        • 7.3.5.1.1.1 Country Overview
        • 7.3.5.1.1.2 Driving Factors for Market Growth
        • 7.3.5.1.1.3 Factors Challenging the Market
        • 7.3.5.1.1.4 Analyst View
        • 7.3.5.1.1.5 Market Sizing and Forecast
      • 7.3.5.1.2 Germany
        • 7.3.5.1.2.1 Country Overview
        • 7.3.5.1.2.2 Driving Factors for Market Growth
        • 7.3.5.1.2.3 Factors Challenging the Market
        • 7.3.5.1.2.4 Analyst View
        • 7.3.5.1.2.5 Market Sizing and Forecast
      • 7.3.5.1.3 France
        • 7.3.5.1.3.1 Country Overview
        • 7.3.5.1.3.2 Driving Factors for Market Growth
        • 7.3.5.1.3.3 Factors Challenging the Market
        • 7.3.5.1.3.4 Analyst View
        • 7.3.5.1.3.5 Market Sizing and Forecast
      • 7.3.5.1.4 Italy
        • 7.3.5.1.4.1 Country Overview
        • 7.3.5.1.4.2 Driving Factors for Market Growth
        • 7.3.5.1.4.3 Factors Challenging the Market
        • 7.3.5.1.4.4 Analyst View
        • 7.3.5.1.4.5 Market Sizing and Forecast
      • 7.3.5.1.5 Spain
        • 7.3.5.1.5.1 Country Overview
        • 7.3.5.1.5.2 Driving Factors for Market Growth
        • 7.3.5.1.5.3 Factors Challenging the Market
        • 7.3.5.1.5.4 Analyst View
        • 7.3.5.1.5.5 Market Sizing and Forecast
      • 7.3.5.1.6 Rest-of-Europe
        • 7.3.5.1.6.1 Country Overview
        • 7.3.5.1.6.2 Driving Factors for Market Growth
        • 7.3.5.1.6.3 Factors Challenging the Market
        • 7.3.5.1.6.4 Analyst View
        • 7.3.5.1.6.5 Market Sizing and Forecast
• 7.4 Asia-Pacific
  • 7.4.1 Regional Overview
  • 7.4.2 Driving Factors for Market Growth
  • 7.4.3 Factors Challenging the Market
  • 7.4.4 Analyst View
  • 7.4.5 Market Sizing and Forecast
    • 7.4.5.1 Asia-Pacific Magnetic Resonance Imaging (MRI) Systems Market, by Country
      • 7.4.5.1.1 China
        • 7.4.5.1.1.1 Country Overview
        • 7.4.5.1.1.2 Driving Factors for Market Growth
        • 7.4.5.1.1.3 Factors Challenging the Market
        • 7.4.5.1.1.4 Analyst View
        • 7.4.5.1.1.5 Market Sizing and Forecast
      • 7.4.5.1.2 Japan
        • 7.4.5.1.2.1 Country Overview
        • 7.4.5.1.2.2 Driving Factors for Market Growth
        • 7.4.5.1.2.3 Factors Challenging the Market
        • 7.4.5.1.2.4 Analyst View
        • 7.4.5.1.2.5 Market Sizing and Forecast
      • 7.4.5.1.3 India
        • 7.4.5.1.3.1 Country Overview
        • 7.4.5.1.3.2 Driving Factors for Market Growth
        • 7.4.5.1.3.3 Factors Challenging the Market
        • 7.4.5.1.3.4 Analyst View
        • 7.4.5.1.3.5 Market Sizing and Forecast
      • 7.4.5.1.4 Australia
        • 7.4.5.1.4.1 Country Overview
        • 7.4.5.1.4.2 Driving Factors for Market Growth
        • 7.4.5.1.4.3 Factors Challenging the Market
        • 7.4.5.1.4.4 Analyst View
        • 7.4.5.1.4.5 Market Sizing and Forecast
      • 7.4.5.1.5 South Korea
        • 7.4.5.1.5.1 Country Overview
        • 7.4.5.1.5.2 Driving Factors for Market Growth
        • 7.4.5.1.5.3 Factors Challenging the Market
        • 7.4.5.1.5.4 Analyst View
        • 7.4.5.1.5.5 Market Sizing and Forecast
      • 7.4.5.1.6 Rest-of-Asia-Pacific
        • 7.4.5.1.6.1 Country Overview
        • 7.4.5.1.6.2 Driving Factors for Market Growth
        • 7.4.5.1.6.3 Factors Challenging the Market
        • 7.4.5.1.6.4 Analyst View
        • 7.4.5.1.6.5 Market Sizing and Forecast
• 7.5 Rest-of-the-World
  • 7.5.1 Regional Overview
  • 7.5.2 Driving Factors for Market Growth
  • 7.5.3 Factors Challenging the Market
  • 7.5.4 Analyst View
  • 7.5.5 Market Sizing and Forecast

8 Competitive Benchmarking and Company Profiles

• 8.1 Key Strategies and Developments, January 2023-March 2026
• 8.2 Key Developments Analysis (by Company)
• 8.3 Company Profiles
  • 8.3.1 ASG Superconductors spa
    • 8.3.1.1 Overview
    • 8.3.1.2 Top Products/Product Portfolio
    • 8.3.1.3 Top Competitors
    • 8.3.1.4 Target Customers
    • 8.3.1.5 Key Personnel
    • 8.3.1.6 Analyst View
  • 8.3.2 AURORA HEALTHCARE US CORP
    • 8.3.2.1 Overview
    • 8.3.2.2 Top Products/Product Portfolio
    • 8.3.2.3 Top Competitors
    • 8.3.2.4 Target Customers
    • 8.3.2.5 Key Personnel
    • 8.3.2.6 Analyst View
  • 8.3.3 Canon Inc.
    • 8.3.3.1 Overview
    • 8.3.3.2 Top Products/Product Portfolio
    • 8.3.3.3 Top Competitors
    • 8.3.3.4 Target Customers
    • 8.3.3.5 Key Personnel
    • 8.3.3.6 Analyst View
  • 8.3.4 Esaote SPA
    • 8.3.4.1 Overview
    • 8.3.4.2 Top Products/Product Portfolio
    • 8.3.4.3 Top Competitors
    • 8.3.4.4 Target Customers
    • 8.3.4.5 Key Personnel
    • 8.3.4.6 Analyst View
  • 8.3.5 FONAR Corporation
    • 8.3.5.1 Overview
    • 8.3.5.2 Top Products/Product Portfolio
    • 8.3.5.3 Top Competitors
    • 8.3.5.4 Target Customers
    • 8.3.5.5 Key Personnel
    • 8.3.5.6 Analyst View
  • 8.3.6 FUJIFILM Holdings Corporation
    • 8.3.6.1 Overview
    • 8.3.6.2 Top Products/Product Portfolio
    • 8.3.6.3 Top Competitors
    • 8.3.6.4 Target Customers
    • 8.3.6.5 Key Personnel
    • 8.3.6.6 Analyst View
  • 8.3.7 GE Healthcare
    • 8.3.7.1 Overview
    • 8.3.7.2 Top Products/Product Portfolio
    • 8.3.7.3 Top Competitors
    • 8.3.7.4 Target Customers
    • 8.3.7.5 Key Personnel
    • 8.3.7.6 Analyst View
  • 8.3.8 Hyperfine, Inc.
    • 8.3.8.1 Overview
    • 8.3.8.2 Top Products/Product Portfolio
    • 8.3.8.3 Top Competitors
    • 8.3.8.4 Target Customers
    • 8.3.8.5 Key Personnel
    • 8.3.8.6 Analyst View
  • 8.3.9 Koninklijke Philips N.V.
    • 8.3.9.1 Overview
    • 8.3.9.2 Top Products/Product Portfolio
    • 8.3.9.3 Top Competitors
    • 8.3.9.4 Target Customers
    • 8.3.9.5 Key Personnel
    • 8.3.9.6 Analyst View
  • 8.3.10 Neusoft Medical Systems Co., Ltd.
    • 8.3.10.1 Overview
    • 8.3.10.2 Top Products/Product Portfolio
    • 8.3.10.3 Top Competitors
    • 8.3.10.4 Target Customers
    • 8.3.10.5 Key Personnel
    • 8.3.10.6 Analyst View
  • 8.3.11 Shanghai United Imaging Healthcare Co., Ltd.
    • 8.3.11.1 Overview
    • 8.3.11.2 Top Products/Product Portfolio
    • 8.3.11.3 Top Competitors
    • 8.3.11.4 Target Customers
    • 8.3.11.5 Key Personnel
    • 8.3.11.6 Analyst View
  • 8.3.12 Siemens Healthineers AG
    • 8.3.12.1 Overview
    • 8.3.12.2 Top Products/Product Portfolio
    • 8.3.12.3 Top Competitors
    • 8.3.12.4 Target Customers
    • 8.3.12.5 Key Personnel
    • 8.3.12.6 Analyst View
  • 8.3.13 SternMed GmbH
    • 8.3.13.1 Overview
    • 8.3.13.2 Top Products/Product Portfolio
    • 8.3.13.3 Top Competitors
    • 8.3.13.4 Target Customers
    • 8.3.13.5 Key Personnel
    • 8.3.13.6 Analyst View
  • 8.3.14 Synaptive Medical
    • 8.3.14.1 Overview
    • 8.3.14.2 Top Products/Product Portfolio
    • 8.3.14.3 Top Competitors
    • 8.3.14.4 Target Customers
    • 8.3.14.5 Key Personnel
    • 8.3.14.6 Analyst View
  • 8.3.15 Time Medical Holding
    • 8.3.15.1 Overview
    • 8.3.15.2 Top Products/Product Portfolio
    • 8.3.15.3 Top Competitors
    • 8.3.15.4 Target Customers
    • 8.3.15.5 Key Personnel
    • 8.3.15.6 Analyst View

9 Research Methodology

• 9.1 Data Sources
  • 9.1.1 Primary Data Sources
  • 9.1.2 Secondary Data Sources
  • 9.1.3 Data Triangulation
• 9.2 Market Estimation and Forecast